The Canadian Intellectual Property Office (CIPO) has materially changed how examiners apply the law on patentable subject matter. In March 2026, CIPO replaced its November 2020 practice notice with an updated framework that specifically addresses computer-implemented inventions and medical diagnostic methods. This shift marks a significant departure from prior guidance, though the source does not detail the exact substance of the new rules.
The source, an analysis from IPWatchdog, compares Canada's updated framework with U.S. practice. It notes that the two jurisdictions differ in how they approach subject matter eligibility, but the article does not provide a point-by-point agreement or disagreement—rather, it presents a comparative overview. Since only this single source is available, the analysis rests entirely on its observations.
Practitioners and applicants should be aware that the 2026 guidance will affect how patent applications in these technology areas are examined in Canada. The source suggests that understanding the differences from U.S. practice is crucial for those filing in both countries, but it does not offer specific examples or case outcomes. Further official CIPO documentation would be needed to fully assess the practical impact.